Post by CTIN (Clinical Trials Information Network)

First patient randomized into a cross-border clinical trial in Europe! We are proud to announce an important milestone: the first randomization of a patient from 🇸🇪 Sweden into a clinical trial conducted at a site in 🇩🇪 Germany. Condition: Multiple System Atrophy (MSA) Our European platform was built to connect patients with clinical trials near their home, but also to open access across borders when local options are not available. This case shows how patients and sites can benefit when barriers of geography and language are removed. Cross-border participation in clinical research is no longer a concept. It is becoming a reality. EU-X-CT - Cross-Border Access to Clinical Trials Initiative, Ingrid Klingmann, H. Lundbeck Norge AS